Variant report
Variant | nsv968113 |
---|---|
Chromosome Location | chr5:116022462-116024990 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:116019394..116021090-chr5:116023279..116025615,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs79947045 | chr5:116022501-116022502 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs75124235 | chr5:116022516-116022517 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548482031 | chr5:116022532-116022533 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562266802 | chr5:116022576-116022577 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192485828 | chr5:116022588-116022589 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540940858 | chr5:116022628-116022629 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551267324 | chr5:116022631-116022632 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138160922 | chr5:116022643-116022644 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183917181 | chr5:116022650-116022651 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571516649 | chr5:116022674-116022675 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs77843619 | chr5:116022750-116022751 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs566849884 | chr5:116022781-116022782 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535985660 | chr5:116022800-116022801 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540053936 | chr5:116022826-116022827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546863490 | chr5:116022827-116022828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188197583 | chr5:116022844-116022845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs149245981 | chr5:116022845-116022846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs77865423 | chr5:116022858-116022859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533480469 | chr5:116022879-116022880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375613038 | chr5:116022943-116022944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2964659 | chr5:116022959-116022960 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs180763065 | chr5:116023000-116023001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7702571 | chr5:116023040-116023041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs150569583 | chr5:116023070-116023071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs541859862 | chr5:116023073-116023074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186395369 | chr5:116023084-116023085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs189681896 | chr5:116023109-116023110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs7702326 | chr5:116023112-116023113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181726403 | chr5:116023183-116023184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185849284 | chr5:116023189-116023190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs559916785 | chr5:116023203-116023204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7702615 | chr5:116023227-116023228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533717957 | chr5:116023244-116023245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs76084000 | chr5:116023268-116023269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7702642 | chr5:116023327-116023328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs7722683 | chr5:116023340-116023341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566818407 | chr5:116023381-116023382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs529274968 | chr5:116023382-116023383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs534709215 | chr5:116023396-116023397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs7703103 | chr5:116023525-116023526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2933614 | chr5:116023562-116023563 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs9327018 | chr5:116023571-116023572 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs78419535 | chr5:116023605-116023606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs4920926 | chr5:116023627-116023628 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs570402574 | chr5:116023682-116023683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs139554616 | chr5:116023696-116023697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs113338520 | chr5:116023705-116023706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572768295 | chr5:116023733-116023734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541475054 | chr5:116023833-116023834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs555424483 | chr5:116023840-116023841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:116016000-116032000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr5:116020800-116022800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr5:116021800-116022600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr5:116021800-116022600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr5:116021800-116022600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr5:116021800-116022800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr5:116022000-116022600 | Enhancers | H1 Cell Line | embryonic stem cell |
8 | chr5:116022200-116022600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr5:116022200-116022600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr5:116022400-116024000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
11 | chr5:116022600-116031000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
12 | chr5:116022800-116029600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
13 | chr5:116022800-116031400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |